Ti=Additional Covenants

1.Ti=Insurance

1.sec={1.Base}  {1.1.Opt} {1.2.Opt}. {1.3.Opt}  {1.4.Opt}

1.Base={The_Company} shall use its commercially reasonable efforts to obtain, within ninety (90) days of the date hereof, from financially sound and reputable insurers Directors and Officers liability insurance and term “key person” insurance on {KeyPersonsInsured}, each in an amount and on terms and conditions satisfactory to the {Board_of_Directors}, and will use commercially reasonable efforts to cause such insurance policies to be maintained until such time as the {Board_of_Directors} determines that such insurance should be discontinued.  The key person policy shall name {the_Company} as loss payee, and neither policy shall be cancelable by {the_Company} without prior approval by the {Board_of_Directors}


1.1.Opt=including the Series A Director

1.2.Opt=and holders of {a majority of} the Preferred Stock

a majority of=a majority of

1.3.Opt=Notwithstanding any other provision of this {AdditionalCovenants.Xref}.1 to the contrary, for so long as a {Series_A_Director} (as defined in {the_Company}’s Certificate of Incorporation) is serving on the {Board_of_Directors}, {the_Company} shall not cease to maintain a Directors and Officers liability insurance policy in an amount of at least [two (2)] million unless approved by such Series A Director, and {the_Company} shall annually, within one hundred twenty (120) days after the end of each fiscal year of {the_Company}, deliver to the Series A Purchasers a certification that such a Directors and Officers liability insurance policy remains in effect.

1.4.Opt=Each {Key_Holder} hereby covenants and agrees that, to the extent such {Key_Holder} is named under such key-person policy, such {Key_Holder} will execute and deliver to {the_Company}, as reasonably requested, a written notice and consent form with respect to such policy.

2.Ti=Employee Agreements

3.sec={The_Company} will cause (i) each person now or hereafter employed by it or by any subsidiary (or engaged by {the_Company} or any subsidiary as a consultant/independent contractor) with access to confidential information and/or trade secrets to enter into a nondisclosure and proprietary rights assignment agreement; and (ii) each {Key_Employee} to enter into a [one (1)] year noncompetition and nonsolicitation agreement[, substantially in the form approved by the {Board_of_Directors}][, in the form attached hereto as Exhibit A].   In addition, {the_Company} shall not amend, modify, terminate, waive, or otherwise alter, in whole or in part, any of the above-referenced agreements or any restricted stock agreement between {the_Company} and any employee, without the [unanimous] consent of the Series A Directors. 

3.Ti=Employee Stock

3.sec=Unless otherwise approved by the {Board_of_Directors}, [including the {Series_A_Director},] all future employees and consultants of {the_Company} who purchase, receive options to purchase, or receive awards of shares of {the_Company}’s capital stock after the date hereof shall be required to execute restricted stock or option agreements, as applicable, providing for (i) vesting of shares over a [four (4)] year period, with the first [twenty-five percent (25%)] of such shares vesting following [twelve (12)] months of continued employment or service, and the remaining shares vesting in equal [monthly] installments over the following [thirty-six (36) months], and (ii) a market stand-off provision substantially similar to that in Subsection 2.11.  In addition, unless otherwise approved by the {Board_of_Directors}, [including the {Series_A_Director},] {the_Company} shall retain a “right of first refusal” on employee transfers until {the_Company}’s IPO and shall have the right to repurchase unvested shares at cost upon termination of employment of a holder of restricted stock.

4.Ti=Qualified Small Business Stock

4.sec={The_Company} shall use commercially reasonable efforts to cause the shares of {SeriesX_Preferred_Stock} [issued pursuant to the {Purchase_Agreement}], as well as any shares into which such shares are converted, within the meaning of Section 1202(f) of the Internal Revenue Code (the “{Code}”), to constitute “qualified small business stock” as defined in Section 1202(c) of the {Code}; provided, however, that such requirement shall not be applicable if the {Board_of_Directors} of {the_Company} determines, in its good-faith business judgment, that such qualification is inconsistent with the best interests of {the_Company}.  {The_Company} shall submit to its stockholders (including {the_Investors}) and to the Internal Revenue Service any reports that may be required under Section 1202(d)(1)(C) of the {Code} and the regulations promulgated thereunder.  In addition, within twenty (20) business days after any {Investor}’s written request therefor, {the_Company} shall, at its option, either (i) deliver to such {Investor} a written statement indicating whether (and what portion of) such {Investor}’s interest in {the_Company} constitutes “qualified small business stock” as defined in Section 1202(c) of the {Code} or (ii) deliver to such {Investor} such factual information in {the_Company}’s possession as is reasonably necessary to enable such {Investor} to determine whether (and what portion of) such {Investor}’s interest in {the_Company} constitutes “qualified small business stock” as defined in Section 1202(c) of the {Code}.

5.Ti=Matters Requiring Investor Director Approval

5.0.Sec=So long as the holders of Series A Preferred Stock are entitled to elect a {Series_A_Director}, {the_Company} hereby covenants and agrees with each of {the_Investors} that it shall not, without approval of the {Board_of_Directors}, which approval must include the affirmative vote of [one/both] of the {Series_A_Directors}:

5.1.Sec=make, or permit any subsidiary to make, any loan or advance to, or own any stock or other securities of, any subsidiary or other corporation, partnership, or other entity unless it is wholly owned by {the_Company};

5.2.Sec=make, or permit any subsidiary to make, any loan or advance to any {Person}, including, without limitation, any employee or director of {the_Company} or any subsidiary, except advances and similar expenditures in the ordinary course of business or under the terms of an employee stock or option plan approved by the {Board_of_Directors};

5.3.Sec=guarantee, directly or indirectly, or permit any subsidiary to guarantee, directly or indirectly, any indebtedness except for trade accounts of {the_Company} or any subsidiary arising in the ordinary course of business;

5.4.Sec=make any investment inconsistent with any investment policy approved by the {Board_of_Directors};

5.5.Sec=incur any aggregate indebtedness in excess of $[_____] that is not already included in a budget approved by the {Board_of_Directors}, other than trade credit incurred in the ordinary course of business;

5.6.Sec=otherwise enter into or be a party to any transaction with any director, officer, or employee of {the_Company} or any “associate” (as defined in Rule 12b-2 promulgated under the Exchange Act) of any such {Person}[, including without limitation any “management bonus” or similar plan providing payments to employees in connection with a Deemed Liquidation Event, as such term is defined in {the_Company}’s Certificate of Incorporation], except for transactions contemplated by {this_Agreement}, the {Purchase_Agreement}, and [_____][; transactions resulting in payments to or by {the_Company} in an aggregate amount less than $[60,000] per year][; or transactions made in the ordinary course of business and pursuant to reasonable requirements of {the_Company}’s business and upon fair and reasonable terms that are approved by a majority of the {Board_of_Directors}];

5.7.Sec=hire, terminate, or change the compensation of the executive officers, including approving any option grants or stock awards to executive officers;

5.8.Sec=change the principal business of {the_Company}, enter new lines of business, or exit the current line of business;

5.9.Sec=sell, assign, license, pledge, or encumber material technology or intellectual property, other than licenses granted in the ordinary course of business; or

5.10.Sec=enter into any corporate strategic relationship involving the payment, contribution, or assignment by {the_Company} or to {the_Company} of money or assets greater than $[100,000].

5.=[01/Agt/Bit/Secs/10]

6.Ti=Board Matters

6.sec=Unless otherwise determined by the vote of a majority of the directors then in office, the {Board_of_Directors} shall meet at least [monthly][quarterly] in accordance with an agreed-upon schedule.  {The_Company} shall reimburse the [nonemployee] directors for all reasonable out-of-pocket travel expenses incurred (consistent with {the_Company}’s travel policy) in connection with attending meetings of the {Board_of_Directors}.  [{The_Company} shall cause to be established, as soon as practicable after such request, and will maintain, an audit and compensation committee, each of which shall consist solely of non-management directors.  Each non-employee director shall be entitled in such person’s discretion to be a member of any Board committee.

7.Ti=Successor Indemnification

7.sec=If {the_Company} or any of its successors or assignees consolidates with or merges into any other {Person} and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of {the_Company} assume the obligations of {the_Company} with respect to indemnification of members of the {Board_of_Directors} as in effect immediately before such transaction, whether such obligations are contained in {the_Company}’s Bylaws, its Certificate of Incorporation, or elsewhere, as the case may be.

8.Ti=Expenses of Counsel

8.sec=In the event of a transaction which is a Sale of {the_Company} (as defined in the Voting Agreement of even date herewith among {the_Investors} and {the_Company}), the reasonable fees and disbursements[, not to exceed $_____,] of one counsel for the [Major] Investors (“{Investor_Counsel}”), in their capacities as stockholders, shall be borne and paid by {the_Company}.  At the outset of considering a transaction which, if consummated would constitute a Sale of {the_Company}, {the_Company} shall obtain the ability to share with the {Investor_Counsel} (and such counsel's clients) and shall share the confidential information (including, without limitation, the initial and all subsequent drafts of memoranda of understanding, letters of intent and other transaction documents and related noncompete, employment, consulting and other compensation agreements and plans) pertaining to and memorializing any of the transactions which, individually or when aggregated with others would constitute the Sale of {the_Company}.  {The_Company} shall be obligated to share (and cause {the_Company}'s counsel and investment bankers to share) such materials when distributed to {the_Company}'s executives and/or any one or more of the other parties to such transaction(s).  In the event that {Investor_Counsel} deems it appropriate, in its reasonable discretion, to enter into a joint defense agreement or other arrangement to enhance the ability of the parties to protect their communications and other reviewed materials under the attorney client privilege, {the_Company} shall, and shall direct its counsel to, execute and deliver to {Investor_Counsel} and its clients such an agreement in form and substance reasonably acceptable to {Investor_Counsel}. In the event that one or more of the other party or parties to such transactions require the clients of {Investor_Counsel} to enter into a confidentiality agreement and/or joint defense agreement in order to receive such information, then {the_Company} shall share whatever information can be shared without entry into such agreement and shall, at the same time, in good faith work expeditiously to enable {Investor_Counsel} and its clients to negotiate and enter into the appropriate agreement(s) without undue burden to the clients of {Investor_Counsel}.]

9.Ti=Indemnification Matters

9.sec={The_Company} hereby acknowledges that one (1) or more of the directors nominated to serve on the {Board_of_Directors} by {the_Investors} (each a “{Fund_Director}”) may have certain rights to indemnification, advancement of expenses and/or insurance provided by one or more of {the_Investors} and certain of their affiliates (collectively, the “{Fund_Indemnitors}”).  {The_Company} hereby agrees (a) that it is the indemnitor of first resort (i.e., its obligations to any such {Fund_Director} are primary and any obligation of the {Fund_Indemnitors} to advance expenses or to provide indemnification for the same expenses or liabilities incurred by such {Fund_Director} are secondary), (b) that it shall be required to advance the full amount of expenses incurred by such {Fund_Director} and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement by or on behalf of any such {Fund_Director} to the extent legally permitted and as required by {the_Company}’s Certificate of Incorporation or Bylaws of {the_Company} (or any agreement between {the_Company} and such {Fund_Director}), without regard to any rights such {Fund_Director} may have against the {Fund_Indemnitors}, and, (c) that it irrevocably waives, relinquishes and releases the {Fund_Indemnitors} from any and all claims against the {Fund_Indemnitors} for contribution, subrogation or any other recovery of any kind in respect thereof.  {The_Company} further agrees that no advancement or payment by the {Fund_Indemnitors} on behalf of any such {Fund_Director} with respect to any claim for which such {Fund_Director} has sought indemnification from {the_Company} shall affect the foregoing and the {Fund_Indemnitors} shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such {Fund_Director} against {the_Company}.

10.Ti=Right to Conduct Activities

10.sec={The_Company} hereby agrees and acknowledges that [insert VC fund entity name] (together with its affiliates) is a professional investment fund, and as such invests in numerous portfolio companies, some of which may be deemed competitive with {the_Company}’s business (as currently conducted or as currently propose to be conducted).  {The_Company} hereby agrees that, to the extent permitted under applicable law, [VC fund] shall not be liable to {the_Company} for any claim arising out of, or based upon, (i) the investment by [VC fund] in any entity competitive with {the_Company}, or (ii) actions taken by any partner, officer or other representative of [VC fund]  to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether or not such action has a detrimental effect on {the_Company}; provided, however, that the foregoing shall not relieve (x) any of {the_Investors} from liability associated with the unauthorized disclosure of {the_Company}’s confidential information obtained pursuant to {this_Agreement}, or (y) any director or officer of {the_Company} from any liability associated with his or her fiduciary duties to {the_Company}.]

11.Ti={FCPA}

11.sec={The_Company} represents that it shall not (and shall not permit any of its subsidiaries or affiliates or any of its or their respective directors, officers, managers, employees, independent contractors, representatives or agents to) promise, authorize or make any payment to, or otherwise contribute any item of value to, directly or indirectly, to any third party, including any Non-U.S. Official (as (as such term is defined in the U.S. Foreign Corrupt Practices Act of 1977, as amended (the “{FCPA}”)), in each case, in violation of the {FCPA}, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. {The_Company} further represents that it shall (and shall cause each of its subsidiaries and affiliates to) cease all of its or their respective activities, as well as remediate any actions taken by {the_Company}, its subsidiaries or affiliates, or any of their respective directors, officers, managers, employees, independent contractors, representatives or agents in violation of the {FCPA}, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law.  {The_Company} further represents that it shall (and shall cause each of its subsidiaries and affiliates to) maintain systems of internal controls (including, but not limited to, accounting systems, purchasing systems and billing systems) to ensure compliance with the {FCPA}, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law.  Upon request, {the_Company} agrees to provide responsive information and/or certifications concerning its compliance with applicable anti-corruption laws.  {The_Company} shall promptly notify each {Investor} if {the_Company} becomes aware of any {Enforcement_Action} (as defined in the {Purchase_Agreement}).  {The_Company} shall, and shall cause any direct or indirect subsidiary or entity controlled by it, whether now in existence or formed in the future, to comply with the {FCPA}.  {The_Company} shall use its best efforts to cause any direct or indirect subsidiary, whether now in existence or formed in the future, to comply in all material respects with all applicable laws.

12.Ti=Termination of Covenants

12.sec=The covenants set forth in this {AdditionalCovenants.Xref}, except for Subsection[s] {AdditionalCovenants.Xnum}.7 [and {AdditionalCovenants.Xref}.8], shall terminate and be of no further force or effect [(i)] immediately before the consummation of the IPO [or][(ii) when {the_Company} first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event, as such term is defined in {the_Company}’s Certificate of Incorporation, whichever event occurs first].

=[01/Agt/Bit/Secs/12]